Maybe but I would guess it has more to do with the recent articles on staffing shortages at Gorgon and Skilled's exposure there through Swan which they did not sell in the end.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor